Seshu Tyagarajan Candel Therapeutics, Inc. (CADL) insider trading activity
Seshu Tyagarajan is Chief Technology Officer of Candel Therapeutics, Inc.. Currently has a direct ownership of 85,512 shares of CADL, which is worth approximately $508,796. The most recent transaction as insider was on Mar 17, 2025, when has been sold 31,278 shares (Common Stock) at a price of $8.82 per share, resulting in proceeds of $275,871. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
85.5K
31.95%
3M change
50.92%
12M change
Total Value Held
$508,796
Seshu Tyagarajan Transaction History
ST
Seshu Tyagarajan
Chief Technology Officer
Needham, MA